Results 281 to 290 of about 1,245,695 (368)
Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity
Isolde Summerer+12 more
doaj +1 more source
Arsenic trioxide transformed acute promyelocytic leukemia therapy and shows promise against HIV. A new method to solubilize the mineral realgar produces different arsenic species depleting the main arsenic target, nuclear PML protein, and retaining effects on leukemic and HIV reservoir cells, while minimizing off‐target damage.
Bojana Lucic+20 more
wiley +1 more source
Effects of intravenous vaccinia in mice with sarcoma 180 or leukemia 9417 [PDF]
Joseph C. Turner, B. Mulliken
openalex +1 more source
Through elaborate design, a biodegradable scaffold with excellent mechanical properties and suitability is fabricated, providing spatial support for subsequent physiological activities. The prepared GA‐HBC‐LIC hydrogel possesses sequential antibacterial, antioxidant, anti‐inflammatory and immunomodulatory functions, offering a suitable chemical and ...
Jiafei Chen+9 more
wiley +1 more source
Case Report: Chronic Granulocytic (Myelogenous) Leukemia and Pregnancy [PDF]
Harold Shub+2 more
openalex +1 more source
Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring
E. Jabbour, H. Kantarjian
semanticscholar +1 more source
A structure‐guided peptide derived from a non‐canonical amino acid library simultaneously targets MCL‐1 and BCL‐xL to overcome apoptotic resistance in acute myeloid leukemia. Fused with a CXCR4‐binding motif, the engineered peptide exhibits selective intracellular delivery and potent in vivo efficacy, offering a promising therapeutic strategy against ...
Zhe Wang+11 more
wiley +1 more source